Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice

被引：9
|
作者：
Tovey, E
Rampes, H
Livingstone, C
机构：
[1] Barnet Enfield & Haringey Mental Hlth NHS Trust, NW Community Mentel Hlth Team, Edgware HA8 7BJ, Middx, England
[2] Royal Surrey Cty Hosp, Dept Clin Biochem, Guildford, Surrey, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2005年 / 19卷 / 02期
关键词：
adverse effect; antipsychotic; clozapine; diabetes mellitus; schizoaffective disorder; schizophrenia;
D O I：
10.1177/0269881105049043
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The atypical antipsychotic clozapine has been reported to be associated with metabolic adverse effects, including type-2 diabetes mellitus. We present two cases of diabetes mellitus associated with clozapine treatment. One case resolved entirely upon withdrawal of the drug, whereas the other did not. We discuss the molecular basis of the diabetogenic action of clozapine and recommendations for monitoring.
引用
收藏
页码：207 / 210
页数：4
相关论文
共 50 条
  • [21] CORRELATION BETWEEN HOMOCYSTEINE AND TYPE-2 DIABETES MELLITUS COMPLICATIONS CORRELATION BETWEEN HOMOCYSTEINE AND TYPE-2 DIABETES MELLITUS COMPLICATIONS
    Akhvlediani, M.
    Emukhvari, M.
    Zabakhidze, N.
    Kvantaliani, T.
    ATHEROSCLEROSIS, 2016, 252 : E135 - E136
  • [22] Type 2 diabetes mellitus and colorectal cancer: possible molecular mechanisms associated
    Ibet Juarez-Vazquez, Clara
    Alejandra Rosales-Reynoso, Monica
    GACETA MEDICA DE MEXICO, 2013, 149 (03): : 322 - 324
  • [23] CLINICAL EFFICACY OF PRAVASTATIN FOR HYPERLIPIDEMIA IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    TAWATA, M
    MIWA, I
    TSUCHIYA, K
    OZAWA, M
    SHINDO, H
    WAKASUGI, M
    ONAYA, T
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (06): : 704 - 708
  • [24] INFLUENCE OF RHEUMATOID ARTHRITIS ON THE CLINICAL AND BIOLOGICAL PROFILE OF TYPE-2 DIABETES MELLITUS
    Avouac, J.
    Elhai, M.
    Forien, M.
    Sellam, J.
    Eymard, F.
    Molto, A.
    Gossec, L.
    Banal, F.
    Daminano, J.
    Dieude, P.
    Allanore, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 597 - 598
  • [25] Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus
    Dogruel, Hakan
    Atlim, Hatice Tuluce
    Aydemir, Mustafa
    Yilmaz, Nusret
    Sari, Ramazan
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (05) : 2189 - 2195
  • [26] Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus
    Hakan Doğruel
    Hatice Tülüce Atlım
    Mustafa Aydemir
    Nusret Yılmaz
    Ramazan Sarı
    Irish Journal of Medical Science (1971 -), 2023, 192 : 2189 - 2195
  • [27] Quality assessment of clinical practice guidelines for management of type 2 diabetes mellitus Assessment of type 2 diabetes mellitus guidelines
    Koc, E. Meltem
    Aksoy, Hilal
    Baser, Duygu Ayhan
    Artantas, Aylin Baydar
    Kahveci, Rabia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 152 : 119 - 124
  • [28] Effects of thiazolidinedione on effort induced angina pectoris with type-2 diabetes mellitus
    Murakami, T
    Mizuno, S
    CIRCULATION, 2000, 102 (18) : 706 - 707
  • [29] Type-2 diabetes mellitus and recovery of rocuronium-induced neuromuscular blockade
    Barrio, J.
    Rauer, F.
    Onrubia, X.
    ANAESTHESIA, 2022, 77 (05) : 612 - 613
  • [30] Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice
    Utzschneider, Kristina M.
    Kowdley, Kris V.
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (01) : 26 - 33
12345